CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia

B-cell receptor (BCR) signaling has been inferred as an important mechanism for disease progression in chronic lymphocytic leukemia (CLL) and other B-cell malignancies. In response to BCR activation, CLL cells secrete the chemokine CCL3, which fosters interactions between CLL cells and the leukemia...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sivina, Mariela, Hartmann, Elena, Kipps, Thomas J., Rassenti, Laura, Krupnik, Diana, Lerner, Susan, LaPushin, Ruth, Xiao, Lianchun, Huang, Xuelin, Werner, Lillian, Neuberg, Donna, Kantarjian, Hagop, O'Brien, Susan, Wierda, William G., Keating, Michael J., Rosenwald, Andreas, Burger, Jan A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2011
Konular:
Lymphoid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318778/
https://ncbi.nlm.nih.gov/pubmed/21115978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-09-307249
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller